Skip to main content

Allergy Program News

Experts from CHOP’s Allergy Program are recognized as global leaders in the management of allergic conditions and have helped formulate many of the national guidelines used by physicians around the world.

Contact us

Crushing Peanut Allergies

Mar 31, 2020

Palforzia TM is a new oral immunotherapy recently approved by the U.S. Food and Drug Administration to treat children with peanut allergies. The medication involves a daily controlled amount of peanut protein designed to desensitize children and reduce the severity of allergic reactions, some of which can be life-threatening.

Infection Prevention and Control

Mar 20, 2020

Reducing a transplant patient’s risk of infection is very important. Here are tips about hygiene and vaccines.

Jump back to top